Our Team

Formulation scientist, innovator, and platform architect driving CasaNova's core technologies. With over three decades of experience in novel nano- and drug delivery technologies, Prof. Kaur focuses on systems that achieve high drug loading, controlled release, and improved permeation — leading to demonstrably better outcomes versus free drug and market controls.

Her work spans 44 patents (22 granted) across drug delivery and nano-engineering, with a proven track record in technology transfer and translational research. She builds scalable platforms that enhance efficacy, safety, and patient compliance — always guided by the belief that science must serve people.

Trained physician and practicing ophthalmologist ensuring clinical relevance and real-world validation of all CasaNova innovations. Dr. Singh brings deep insight into patient needs, disease pathology, and treatment gaps — guiding target product profiles and clinical translation pathways.

He bridges bench-to-bedside execution and adoption strategy, anchoring every innovation in outcomes, usability, and physician acceptance. The scientist-clinician synergy at CasaNova's core enables faster translation from concept to clinic.